Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.
This study assessed the acute effect of intravenous conjugated equine estrogen on metabolic coronary vasodilation to atrial pacing in 22 postmenopausal women with coronary disease or risk factors for atherosclerosis. Impaired metabolic coronary vasodilation is present in postmenopausal women with atherosclerosis or its risk factors and is not acutely augmented by the intravenous administration of Premarin.
Anderson
T J
TJ
Department of Medicine, University of Calgary, Alberta, Canada.
D000368:Aged; D000416:Alberta; D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017698:Postmenopause; D014664:Vasodilation / Q000187:drug effects*; D016387:Women's Health
D004966:Estrogens, Conjugated (USP)